# Christopher Reyes

> Christopher Reyes is a biophysicist turned serial biotech entrepreneur and the CEO, co-founder, and director of Bloom Science, a San Diego company developing living medicines that harness the gut-brain axis. Bloom's lead program, BL-001, is a first-in-class oral live biotherapeutic designed to replicate the anti-seizure effects of the ketogenic diet, built on technology licensed from UCLA. With a PhD in biophysics from UCSF and a track record that includes a fast-acquired cancer startup, Reyes is betting that genetically optimized gut bacteria can treat pharmacoresistant neurological diseases.

- **Role:** CEO, Co-Founder & Director at Bloom Science, Inc.
- **Organizations:** Bloom Science, Inc., Hey Social Good, PBC, Eclipse Therapeutics, Biogen Idec, The Scripps Research Institute
- **Nationality:** American
- **Education:** PhD, Biophysics, University of California, San Francisco (UCSF), BA, Molecular and Cell Biology and Biophysics, University of California, Berkeley, Postdoctoral Fellow, The Scripps Research Institute
- **Known for:** Co-founded and leads Bloom Science, developing first-in-class live biotherapeutic products for neurological disease, Raised $12 million Series A financing for Bloom Science (December 2021), Co-founded Eclipse Therapeutics, a cancer stem cell startup acquired within 18 months

## Career timeline

- **2002-2006** — Postdoctoral Fellow at The Scripps Research Institute
- **2006-2011** — Scientist, Molecular Discovery at Biogen Idec
- **2011-2012** — Co-Founder, Chief Scientific Officer & Director at Eclipse Therapeutics; acquired within 18 months
- **2017-2020** — Co-Founder & Director, acting CTO at Hey Social Good, PBC
- **2018** — Bloom Science launches with exclusive technology license from UCLA
- **2021-12** — Bloom Science raises $12M Series A financing

## Achievements

- Co-founded and leads Bloom Science, developing first-in-class live biotherapeutic products for neurological disease
- Raised $12 million Series A financing for Bloom Science (December 2021)
- Co-founded Eclipse Therapeutics, a cancer stem cell startup acquired within 18 months
- Secured exclusive technology license from UCLA based on Cell-published research on the gut microbiota and the ketogenic diet
- Recipient of National Science Foundation and Ford Foundation fellowships; McNair Scholar

## Latest updates

- **2021-12** — Bloom Science raised $12 million in Series A financing to advance BL-001 toward an IND filing and Phase I trials in refractory epilepsy.
- **2023-05** — Bloom Science named biotechnology executive Dr. Grace E. Colon as Board Chair.

## Links

- Website: https://bloomscience.com
- LinkedIn: http://www.linkedin.com/in/christopher-reyes-phd-80b719
- Twitter/X: https://twitter.com/bloomscience?lang=en
- YouTube: https://www.youtube.com/watch?v=WRNprMXDr5g
- Facebook: https://facebook.com/bloomscience/

---

Profile page: https://yespress.io/christopher-reyes
Published by YesPress — https://yespress.io
Last updated: 2026-06-14